| Product Code: ETC13364647 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Pediatric Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Pediatric Vaccine Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Pediatric Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Pediatric Vaccine Market - Industry Life Cycle |
3.4 Europe Pediatric Vaccine Market - Porter's Five Forces |
3.5 Europe Pediatric Vaccine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Pediatric Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Europe Pediatric Vaccine Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 Europe Pediatric Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Europe Pediatric Vaccine Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Europe Pediatric Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
4 Europe Pediatric Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Pediatric Vaccine Market Trends |
6 Europe Pediatric Vaccine Market, 2021 - 2031 |
6.1 Europe Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Pediatric Vaccine Market, Revenues & Volume, By Live Attenuated, 2021 - 2031 |
6.1.3 Europe Pediatric Vaccine Market, Revenues & Volume, By Inactivated, 2021 - 2031 |
6.1.4 Europe Pediatric Vaccine Market, Revenues & Volume, By Subunit, 2021 - 2031 |
6.1.5 Europe Pediatric Vaccine Market, Revenues & Volume, By Toxoid, 2020 - 2028 |
6.1.6 Europe Pediatric Vaccine Market, Revenues & Volume, By Conjugate, 2020 - 2028 |
6.2 Europe Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Pediatric Vaccine Market, Revenues & Volume, By Respiratory Infections, 2021 - 2031 |
6.2.3 Europe Pediatric Vaccine Market, Revenues & Volume, By Gastrointestinal Diseases, 2021 - 2031 |
6.2.4 Europe Pediatric Vaccine Market, Revenues & Volume, By Neurological Diseases, 2021 - 2031 |
6.2.5 Europe Pediatric Vaccine Market, Revenues & Volume, By Bloodborne Diseases, 2021 - 2031 |
6.2.6 Europe Pediatric Vaccine Market, Revenues & Volume, By Bacterial Infections, 2020 - 2028 |
6.3 Europe Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Pediatric Vaccine Market, Revenues & Volume, By mRNA, 2021 - 2031 |
6.3.3 Europe Pediatric Vaccine Market, Revenues & Volume, By Recombinant, 2021 - 2031 |
6.3.4 Europe Pediatric Vaccine Market, Revenues & Volume, By DNA-Based, 2021 - 2031 |
6.3.5 Europe Pediatric Vaccine Market, Revenues & Volume, By Viral Vector, 2021 - 2031 |
6.3.6 Europe Pediatric Vaccine Market, Revenues & Volume, By Protein Subunit, 2021 - 2031 |
6.4 Europe Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Pediatric Vaccine Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Europe Pediatric Vaccine Market, Revenues & Volume, By Pediatric Clinics, 2021 - 2031 |
6.4.4 Europe Pediatric Vaccine Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
6.4.5 Europe Pediatric Vaccine Market, Revenues & Volume, By Government Programs, 2020 - 2028 |
6.4.6 Europe Pediatric Vaccine Market, Revenues & Volume, By Pharmacies, 2020 - 2028 |
6.5 Europe Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe Pediatric Vaccine Market, Revenues & Volume, By Infants, 2020 - 2028 |
6.5.3 Europe Pediatric Vaccine Market, Revenues & Volume, By Children, 2020 - 2028 |
6.5.4 Europe Pediatric Vaccine Market, Revenues & Volume, By Adolescents, 2020 - 2028 |
6.5.5 Europe Pediatric Vaccine Market, Revenues & Volume, By Neonates, 2020 - 2028 |
6.5.6 Europe Pediatric Vaccine Market, Revenues & Volume, By Pre-Teens, 2020 - 2028 |
7 Europe Pediatric Vaccine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 Germany Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 France Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.4 Poland Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.5 Spain Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.6 Rest of Europe Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 Europe Pediatric Vaccine Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
7.3.1 United Kingdom (UK) Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.2 Germany Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.3 France Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.4 Poland Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.5 Spain Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.6 Rest of Europe Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4 Europe Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.1 United Kingdom (UK) Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.2 Germany Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.3 France Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.4 Poland Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.5 Spain Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.6 Rest of Europe Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 Europe Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United Kingdom (UK) Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Germany Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 France Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Poland Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.5 Spain Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.6 Rest of Europe Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 Europe Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6.1 United Kingdom (UK) Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6.2 Germany Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6.3 France Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6.4 Poland Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6.5 Spain Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6.6 Rest of Europe Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
8 Europe Pediatric Vaccine Market Key Performance Indicators |
9 Europe Pediatric Vaccine Market - Export/Import By Countries Assessment |
10 Europe Pediatric Vaccine Market - Opportunity Assessment |
10.1 Europe Pediatric Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Pediatric Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 Europe Pediatric Vaccine Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.4 Europe Pediatric Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.5 Europe Pediatric Vaccine Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 Europe Pediatric Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
11 Europe Pediatric Vaccine Market - Competitive Landscape |
11.1 Europe Pediatric Vaccine Market Revenue Share, By Companies, 2022 |
11.2 Europe Pediatric Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here